SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Issue of Equity

10 Jan 2020 13:30

RNS Number : 4848Z
Sabien Technology Group PLC
10 January 2020
 

For immediate release

10 January 2020

Sabien Technology Group plc

("Sabien" or the "Company")

Issue of equity

The Board of Sabien is pleased to announce that the placing of 200,000,000 new ordinary shares (the "Placing Shares") with new and existing investors, at a price of 0.15 pence per Placing Share (the "Placing Price") was approved by shareholders at the General Meeting held on 8 January 2020 and the Placing Shares commenced trading on AIM with effect from 9 January 2020 (the "Placing").

As previously announced, the Company's largest shareholder, Truell Intergenerational Family Limited Partnership ("TIG"), subscribed for 20,000,000 Placing Shares at the Placing Price and is now interested in 316,751,623 ordinary shares representing 22.84 per cent. of the enlarged issued share capital. TIG had previously been interested in 25.0 per cent. of the Company's issued share capital and had expressed an interest to subscribe for further new ordinary shares at the Placing Price to maintain its interest at 25.0 per cent. The Board of Sabien has now agreed today to issue 46,666,667 new ordinary shares at the Placing Price to TIG ("Subscription"). Following completion of the Subscription and the further issue of equity set out below, TIG will be interested in 25.0 per cent. of the enlarged issued share capital.

The proceeds of the Subscription amount to £70,000 and will be used to provide additional working capital for the continued development of the Company, in line with its stated strategy. Together with existing cash balances (including the proceeds of the Placing) the Company's current cash balances will amount to approximately £820,000. In order to maximise the Company's cash funds available for new investment, the Board has also agreed today to settle accrued but unpaid directors fees due to Cédriane de Boucaud Truell and Marco Nijhof (amounting to £15,000 each) in new ordinary shares ("Fee Shares"), also to be issued at the Placing Price. Accordingly, the Board has issued 10,000,000 new ordinary shares to each of Cédriane de Boucaud Truell and Marco Nijhof (neither of whom previously held any ordinary shares), and who will each be interested in 0.69 per cent of the enlarged issued share capital of the Company.

Once issued, the Subscription Shares and the Fee Shares (together the "New Shares") will rank pari passu with the Company's existing ordinary shares. Application will be made for the New Shares to be admitted to trading on AIM ("Admission") on or around 16 January 2020. The New Shares in aggregate represent 4.8 per cent. of the current issued share capital of the Company.

Richard Parris said:

"These additional funds further strengthen the Company's position to respond to possible business opportunities and broadens the alignment of Directors interests with those of our shareholders."

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("FCA") Sabien announces that as at today's date the Company's issued share capital consists of 1,453,673,157 Ordinary Shares of 0.01p each with voting rights. The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 1,453,673,157.

The above figure of 1,453,673,157 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Special note concerning the Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR").

The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman.

For further information:

Sabien Technology Group plc

Richard Parris and Cédriane de Boucaud Truell

+44(0)20 7993 3700

Beaumont Cornish Limited (Nominated Advisor)

Michael Cornish and Roland Cornish

www.beaumontcornish.com

+44(0)20 7628 3396

Peterhouse Capital Limited (Broker)

Duncan Vasey and Lucy Williams

+44(0)20 7469 0930

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Cédriane de Boucaud Truell

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Sabien Technology Group plc

b)

 

LEI

 

213800S5QG1SMGHFHY68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.01p each ("Ordinary Shares")

 

Identification code

ISIN: GB00B1FPCD38

 

b)

 

Nature of the transaction

 

Settlement of directors' fees in Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volumes(s)

£0.15

10,000,000

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

10 January 2019

f)

 

Place of the transaction

 

London Stock Exchange

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Marco Nijhof

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Sabien Technology Group plc

b)

 

LEI

 

213800S5QG1SMGHFHY68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.01p each ("Ordinary Shares")

 

Identification code

ISIN: GB00B1FPCD38

 

b)

 

Nature of the transaction

 

Settlement of directors' fees in Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volumes(s)

£0.15

10,000,000

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

10 January 2019

f)

 

Place of the transaction

 

London Stock Exchange

XLON

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEKKKBDNBKDBDD
Date   Source Headline
11th Jun 20267:00 amRNSIssue of shares to directors & broker
2nd Jun 20267:00 amRNSProposed balance sheet strengthening & M2G update
29th May 20265:00 pmRNSTotal Voting Rights
21st May 20267:00 amRNSProposed Commercial Partnership & Investment
20th May 20266:22 pmRNSSettlement of Historical Contract
31st Mar 20267:00 amRNSHalf-year Report for the 6 months to 31 Dec 2025
10th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Jan 20265:30 pmRNSHolding(s) in Company
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
9th Dec 20251:20 pmRNSResult of Annual General Meeting
9th Dec 20257:00 amRNSAGM Statement & Trading Update
19th Nov 20257:00 amRNSProposed Strategic Agreement with COF
13th Nov 20257:00 amRNSFinal Results for the Year Ended 30 June 2025
10th Nov 20257:00 amRNSNew Factoring Facility
5th Nov 202512:01 pmRNSAppointment of Corporate Broker
2nd Oct 202512:06 pmRNSFurther update on Sabien, b.grn & related matters
19th Sep 20257:00 amRNSTrading Update
31st Jul 20254:59 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSYear End Trading Update
30th Jun 20252:53 pmRNSIssue of shares to directors
23rd Jun 20254:28 pmRNSHolding(s) in Company
17th Mar 20257:00 amRNSHalf-year Report for the 6 months to 31 Dec 2024
6th Feb 202511:43 amRNSUpdate in relation to Aeristech Limited
27th Jan 20257:00 amRNSTrading update - acceleration of new M2G orders
31st Dec 202412:30 pmRNSTotal Voting Rights
19th Dec 202410:51 amRNSResult of Annual General Meeting
19th Dec 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
28th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSIssue of shares to non-executive directors
18th Nov 20247:00 amRNSFinal Results & Annual Report & Accounts for 2024
11th Nov 20247:00 amRNSNew M2G Cloud Connection System Order
17th Oct 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
30th Sep 20245:00 pmRNSTotal Voting Rights
26th Sep 20244:21 pmRNSDirector/PDMR Shareholding
19th Sep 20241:00 pmRNSHolding(s) in Company
4th Sep 20245:30 pmRNSAdmission of New Shares & Total Voting Rights
29th Aug 20244:00 pmRNSUpdate on Admission of New Ordinary Shares
20th Aug 20247:00 amRNSRelated Party Funding
8th Jul 20248:15 amRNSTrading Statement
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.